Lowell T Nicholson
Overview
Explore the profile of Lowell T Nicholson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ney Z, Nicholson L, Madigan L
JAAD Case Rep
. 2024 Nov;
53:170-173.
PMID: 39555313
No abstract available.
2.
Nicholson L, Cowen E, Beck D, Ferrada M, Madigan L
JID Innov
. 2023 Dec;
4(1):100242.
PMID: 38130326
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome is a newly recognized, acquired autoinflammatory disorder with broad systemic implications and a poor global prognosis. Because cutaneous lesions are present in the...
3.
DAnniballe V, Huang M, Lueck B, Nicholson L, McFatridge I, Gunn M
J Immunother
. 2023 Sep;
46(9):333-340.
PMID: 37737688
Undifferentiated monocytes can be loaded with tumor antigens (Ag) and administered intravenously to induce antitumor cytotoxic T lymphocyte (CTL) responses. This vaccination strategy exploits an endogenous Ag cross-presentation pathway, where...
4.
Nicholson L, Topham C, Curtis J, Madigan L
JAAD Case Rep
. 2022 Oct;
29:146-148.
PMID: 36275875
No abstract available.
5.
Huang M, Nicholson L, Batich K, Swartz A, Kopin D, Wellford S, et al.
J Clin Invest
. 2019 Oct;
130(2):774-788.
PMID: 31661470
Efficacy of dendritic cell (DC) cancer vaccines is classically thought to depend on their antigen-presenting cell (APC) activity. Studies show, however, that DC vaccine priming of cytotoxic T lymphocytes (CTLs)...
6.
Smith J, Nicholson L, Suwanpradid J, Glenn R, Knape N, Alagesan P, et al.
Sci Signal
. 2018 Nov;
11(555).
PMID: 30401786
The chemokine receptor CXCR3 plays a central role in inflammation by mediating effector/memory T cell migration in various diseases; however, drugs targeting CXCR3 and other chemokine receptors are largely ineffective...
7.
Hanappe M, Nicholson L, Elmore S, Fehr A, Bigirimana J, Borg R, et al.
J Glob Oncol
. 2018 Oct;
4:1-12.
PMID: 30321096
Purpose: Low- and middle-income countries disproportionately comprise 65% of cancer deaths. Cancer care delivery in resource-limited settings, especially low-income countries in sub-Saharan Africa, is exceedingly complex, requiring multiple modalities of...